HSPD1 and chronic atrophic gastritis: EV-associated Hsp60 may also serve as a surrogate marker of mucosal immune dysregulation [50], helping to stratify patients at higher risk for progression to atrophic gastritis, intestinal metaplasia, or gastric cancer.